-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US1280583022 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 40M |
|---|---|
| PE Ratio | None |
| Target Price | 11.3333 |
| Beta | 1.27 |
| Dividend Yield | None |
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LSTA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026